Luminex wins BARDA funding to develop SARS-CoV-2 and Flu/RSV multiplex assay

Luminex has secured BARDA funding for ARIES Flu A/B & RSV+SARS-CoV-2 Assay. (Credit: Pete Linforth from Pixabay)



Related Article
Recommended Whitepaper

View More